US5043107A
(en)
*
|
1986-08-21 |
1991-08-27 |
Vestar Research, Inc. |
Preparation small unilamellar vesicles including polyene antifungal antibiotics
|
AU598958B2
(en)
*
|
1987-11-12 |
1990-07-05 |
Vestar, Inc. |
Improved amphotericin b liposome preparation
|
EP0442962B1
(en)
*
|
1988-11-09 |
1994-01-05 |
UNGER, Evan C |
Liposomal radiologic contrast agents
|
US5469854A
(en)
|
1989-12-22 |
1995-11-28 |
Imarx Pharmaceutical Corp. |
Methods of preparing gas-filled liposomes
|
US5580575A
(en)
*
|
1989-12-22 |
1996-12-03 |
Imarx Pharmaceutical Corp. |
Therapeutic drug delivery systems
|
US5088499A
(en)
*
|
1989-12-22 |
1992-02-18 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
US5656211A
(en)
|
1989-12-22 |
1997-08-12 |
Imarx Pharmaceutical Corp. |
Apparatus and method for making gas-filled vesicles of optimal size
|
US5352435A
(en)
*
|
1989-12-22 |
1994-10-04 |
Unger Evan C |
Ionophore containing liposomes for ultrasound imaging
|
US6551576B1
(en)
|
1989-12-22 |
2003-04-22 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5585112A
(en)
|
1989-12-22 |
1996-12-17 |
Imarx Pharmaceutical Corp. |
Method of preparing gas and gaseous precursor-filled microspheres
|
US6088613A
(en)
|
1989-12-22 |
2000-07-11 |
Imarx Pharmaceutical Corp. |
Method of magnetic resonance focused surgical and therapeutic ultrasound
|
US5334381A
(en)
*
|
1989-12-22 |
1994-08-02 |
Unger Evan C |
Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
|
US6146657A
(en)
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US5542935A
(en)
|
1989-12-22 |
1996-08-06 |
Imarx Pharmaceutical Corp. |
Therapeutic delivery systems related applications
|
US5733572A
(en)
|
1989-12-22 |
1998-03-31 |
Imarx Pharmaceutical Corp. |
Gas and gaseous precursor filled microspheres as topical and subcutaneous delivery vehicles
|
US5305757A
(en)
|
1989-12-22 |
1994-04-26 |
Unger Evan C |
Gas filled liposomes and their use as ultrasonic contrast agents
|
US5705187A
(en)
|
1989-12-22 |
1998-01-06 |
Imarx Pharmaceutical Corp. |
Compositions of lipids and stabilizing materials
|
US6001335A
(en)
|
1989-12-22 |
1999-12-14 |
Imarx Pharmaceutical Corp. |
Contrasting agents for ultrasonic imaging and methods for preparing the same
|
US5773024A
(en)
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5776429A
(en)
|
1989-12-22 |
1998-07-07 |
Imarx Pharmaceutical Corp. |
Method of preparing gas-filled microspheres using a lyophilized lipids
|
US5922304A
(en)
|
1989-12-22 |
1999-07-13 |
Imarx Pharmaceutical Corp. |
Gaseous precursor filled microspheres as magnetic resonance imaging contrast agents
|
US5246707A
(en)
*
|
1990-04-26 |
1993-09-21 |
Haynes Duncan H |
Sustained release delivery of water-soluble bio-molecules and drugs using phospholipid-coated microcrystals, microdroplets and high-concentration liposomes
|
US5091188A
(en)
*
|
1990-04-26 |
1992-02-25 |
Haynes Duncan H |
Phospholipid-coated microcrystals: injectable formulations of water-insoluble drugs
|
US5215680A
(en)
*
|
1990-07-10 |
1993-06-01 |
Cavitation-Control Technology, Inc. |
Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles
|
DK0555317T3
(da)
*
|
1990-10-09 |
1995-08-07 |
Nexstar Pharmaceuticals Inc |
Phospholipid-analog-vesikel med en succinimidylsubstituent
|
US5205290A
(en)
|
1991-04-05 |
1993-04-27 |
Unger Evan C |
Low density microspheres and their use as contrast agents for computed tomography
|
US5874062A
(en)
|
1991-04-05 |
1999-02-23 |
Imarx Pharmaceutical Corp. |
Methods of computed tomography using perfluorocarbon gaseous filled microspheres as contrast agents
|
US5464696A
(en)
*
|
1992-08-13 |
1995-11-07 |
Bracco International B.V. |
Particles for NMR imaging
|
WO1994026253A1
(en)
*
|
1993-05-19 |
1994-11-24 |
The Liposome Company, Inc. |
Liposome having a multicomponent bilayer which contains a bioactive agent as an integral component of the bilayer
|
US5411730A
(en)
*
|
1993-07-20 |
1995-05-02 |
Research Corporation Technologies, Inc. |
Magnetic microparticles
|
US5736121A
(en)
|
1994-05-23 |
1998-04-07 |
Imarx Pharmaceutical Corp. |
Stabilized homogenous suspensions as computed tomography contrast agents
|
US5630786A
(en)
*
|
1994-06-27 |
1997-05-20 |
Ionix Corporation |
Boron neutron capture enhancement of fast neutron therapy
|
US6743779B1
(en)
|
1994-11-29 |
2004-06-01 |
Imarx Pharmaceutical Corp. |
Methods for delivering compounds into a cell
|
DE19500665A1
(de)
*
|
1995-01-12 |
1996-07-18 |
Axel Prof Dr Haase |
Verfahren zur ortsauflösenden Abbildung eines Bereiches eines biologischen Objektes mit Hilfe elektromagnetischer Strahlen unter Applikation von Kontrastmittel
|
US5830430A
(en)
|
1995-02-21 |
1998-11-03 |
Imarx Pharmaceutical Corp. |
Cationic lipids and the use thereof
|
US5997898A
(en)
|
1995-06-06 |
1999-12-07 |
Imarx Pharmaceutical Corp. |
Stabilized compositions of fluorinated amphiphiles for methods of therapeutic delivery
|
US6521211B1
(en)
|
1995-06-07 |
2003-02-18 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Methods of imaging and treatment with targeted compositions
|
US6139819A
(en)
|
1995-06-07 |
2000-10-31 |
Imarx Pharmaceutical Corp. |
Targeted contrast agents for diagnostic and therapeutic use
|
US6033645A
(en)
|
1996-06-19 |
2000-03-07 |
Unger; Evan C. |
Methods for diagnostic imaging by regulating the administration rate of a contrast agent
|
US6231834B1
(en)
|
1995-06-07 |
2001-05-15 |
Imarx Pharmaceutical Corp. |
Methods for ultrasound imaging involving the use of a contrast agent and multiple images and processing of same
|
DE69637441T2
(de)
|
1995-10-17 |
2009-03-05 |
Jagotec Ag |
Verabreichung unlöslicher arzneistoffe
|
DE69736981D1
(de)
|
1996-05-01 |
2007-01-04 |
Imarx Pharmaceutical Corp |
In vitro verfahren zum einbringen von nukleinsäuren in eine zelle
|
US6465016B2
(en)
|
1996-08-22 |
2002-10-15 |
Research Triangle Pharmaceuticals |
Cyclosporiine particles
|
US6414139B1
(en)
|
1996-09-03 |
2002-07-02 |
Imarx Therapeutics, Inc. |
Silicon amphiphilic compounds and the use thereof
|
ATE231004T1
(de)
|
1996-09-11 |
2003-02-15 |
Imarx Pharmaceutical Corp |
Verbesserte verfahren zur diagnostischen bilderzeugung unter verwendung eines kontrastmittels und eines vasodilators
|
US5846517A
(en)
|
1996-09-11 |
1998-12-08 |
Imarx Pharmaceutical Corp. |
Methods for diagnostic imaging using a renal contrast agent and a vasodilator
|
FR2754828B1
(fr)
*
|
1996-10-23 |
1998-12-24 |
Univ Toulouse |
Structure membranaire artificielle, procede et polymere pour sa preparation, procede de preparation de ce polymere, particule et film comprenant cette structure
|
US6120751A
(en)
|
1997-03-21 |
2000-09-19 |
Imarx Pharmaceutical Corp. |
Charged lipids and uses for the same
|
US6143276A
(en)
|
1997-03-21 |
2000-11-07 |
Imarx Pharmaceutical Corp. |
Methods for delivering bioactive agents to regions of elevated temperatures
|
US6090800A
(en)
|
1997-05-06 |
2000-07-18 |
Imarx Pharmaceutical Corp. |
Lipid soluble steroid prodrugs
|
US6537246B1
(en)
|
1997-06-18 |
2003-03-25 |
Imarx Therapeutics, Inc. |
Oxygen delivery agents and uses for the same
|
US6416740B1
(en)
|
1997-05-13 |
2002-07-09 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Acoustically active drug delivery systems
|
US6548047B1
(en)
|
1997-09-15 |
2003-04-15 |
Bristol-Myers Squibb Medical Imaging, Inc. |
Thermal preactivation of gaseous precursor filled compositions
|
US6123923A
(en)
|
1997-12-18 |
2000-09-26 |
Imarx Pharmaceutical Corp. |
Optoacoustic contrast agents and methods for their use
|
US20010003580A1
(en)
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
ATE259220T1
(de)
|
1998-05-29 |
2004-02-15 |
Skyepharma Canada Inc |
Gegen hitzeeinwirkung geschützte mikropartikel und verfahren zur terminalen dampfsterilisation derselben
|
SK288117B6
(sk)
|
1998-11-20 |
2013-09-03 |
Skyepharma Canada Inc. |
Rapidly dispersing solid dry therapeutic dosage form
|
JP5102423B2
(ja)
|
2000-04-20 |
2012-12-19 |
オバン・エナジー・リミテッド |
改善された水不溶性薬剤粒子の処理
|
ATE424811T1
(de)
|
2000-08-31 |
2009-03-15 |
Jagotec Ag |
Gemahlene partikel
|
DE10331439B3
(de)
|
2003-07-10 |
2005-02-03 |
Micromod Partikeltechnologie Gmbh |
Magnetische Nanopartikel mit verbesserten Magneteigenschaften
|
JPWO2006028129A1
(ja)
*
|
2004-09-10 |
2008-05-08 |
東レ株式会社 |
医薬品製剤
|
RU2481125C2
(ru)
|
2006-12-18 |
2013-05-10 |
Колороббия Италия С.П.А. |
Магнитные наночастицы для применения при гипертермии, их приготовление и применение в магнитных системах для фармакологического использования
|
EP2719398B1
(en)
*
|
2011-06-13 |
2016-01-20 |
National University Corporation Chiba University |
Medical tissue-marker and manufacturing method for same
|
JP6482604B2
(ja)
*
|
2017-06-22 |
2019-03-13 |
教裕 南郷 |
外皮内溶解型ニードル及びニードル装置
|
CN110455848B
(zh)
*
|
2018-05-08 |
2024-02-23 |
国家纳米科学中心 |
基于络合反应放大信号的铁离子纵向弛豫时间传感器及其构建方法、用途
|
EP3714879A1
(en)
*
|
2019-03-28 |
2020-09-30 |
Sisaf Ltd |
Structured encapsulated silicon-containing particles
|